Attending #AACR26 next week and interested in #RealWorldEvidence and #ClinicalTrial design? Don't miss Session MW04: Clinical Trial Design Workshop chaired by @eaonc.bsky.social Group Co Chair Dr. Peter O'Dwyer
🗓 Apr 17 | 3–4:30 PM | Room 31 #RWE #CancerResearch

A real‑world retrospective study in Ther Adv Med Oncol examined the prevalence of HER2‑ultralow disease in HR+/HER2‑negative metastatic breast cancer and reported comparable first‑line chemotherapy outcomes to HER2‑low disease.
buff.ly/Q7JaadR
#BreastCancer #HER2 #MedicalOncology #RealWorldEvidence

Expertise that you can rely on - rely on the PHARMO Institute for your complex research questions.

Why Work With PHARMO?
- Scientific rigor
- Global collaboration
- Proven track record

Explore more: lumanity.com/capabilities...

#RWE #RWD #RealWorldEvidence

The resident doctors' strike dominates the headlines. But this week's episode isn't really about the strike, it's about what the strike reveals.
🎙️ New episode out now.
#HEOR #HealthEconomics #HealthcarePolicy #NHS #ResidentDoctors #HealthcareDecisions #Podcast #RealWorldEvidence #HealthPolicy

在項目招標和職位招聘廣告中頻頻出現的“真實世界數據”real world evidence是神馬東東？一個卡通版科普簡介 #realworldevidence youtu.be/Nd8uBCYdno0?...

📊 How can #RealWorldData strengthen cancer #ClinicalTrial design? At #AACR26, join Session MW04: Clinical Trial Design Workshop – #RealWorldEvidence in Clinical Trial Design, chaired by @eaonc.bsky.social Group Co Chair Dr. Peter O'Dwyer🗓 Apr 17 | 3–4:30 PM | Room 31 #RWE #CancerResearch

Medical professional and child in hospital. Learn more about our RWE expertise in Dravet syndrome

Our experts have developed an algorithmic approach to identifying patients with Dravet syndrome in #RWD. Our analysis of hospital and patient data gives unparalleled insight into the effectiveness and safety outcomes of treatments. Read on: buff.ly/hMYVFsR

#RealWorldEvidence #DravetSyndrome #RWE

We're live from the #EVIDENCE360 RWE, Pricing & Market Access Summit. Connect with our on-site expert, Mateo Delclaux to discuss how RWE can add value across the product lifecycle.

#EVIDENCE360 #RWE #MarketAcccess #RealWorldEvidence

ジョンソン・エンド・ジョンソン、mCSPCでERLEADAがダロルタミド比で死亡リスク51％低減──24か月追跡のリアルワールド解析 | STELLANEWS.LIFE STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見 | STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見

Johnson & Johnson: ERLEADA Associated with 51% Lower Risk of Death Compared to Darolutamide in Real-World Analysis of Patients with mCSPC

stellanews.life/technology/8...

#ProstateCancer #ERLEADA #RealWorldEvidence #Oncology #JandJ #Apalutamide

🚀 Join RADeep team at @vhir.bsky.social in Barcelona! 🚀

🔹 Data Engineer
👉 lnkd.in/d6Mkwg5q
🔹 Data Manager
👉 lnkd.in/dBsZrTXF

#Hiring #DataEngineer #DataManager #RealWorldEvidence #CareerOpportunity #RADeep #RADs

Analysis of 346 BCBM cases from the GEICAM RegistEM registry reveals faster CNS progression and poorer survival in TNBC and HER2+ subtypes, with major differences between de novo vs subsequent brain metastases.
🔗 buff.ly/74yHwuH
#BreastCancer #BrainMets #HER2 #TNBC #RealWorldEvidence

RWE Guidance Infographic and Updates

The regulatory landscape for #RealWorldEvidence has accelerated over the past decade, with new and updated guidance across regions and agencies. Without proactive planning, these can delay studies and increase costs and risks. Stay ahead: buff.ly/OPSIGsv

#RWE #PASS

We're looking forward to the upcoming 2nd Annual EVIDENCE 360: RWE, Pricing & Market Access Summit. Will you be there? Connect with us on-site to discuss how RWE can add value across the product lifecycle. Email contact@lumanity.com

#EVIDENCE360 #RWE #MarketAcccess #RealWorldEvidence

ECCO26 data reinforce long-term durability and real-world impact of AbbVie’s IBD portfolio Real-world data and three-year trial results show sustained remission and symptom control with Skyrizi and Rinvoq.

New data at ECCO 2026: Risankizumab & upadacitinib show sustained remission & real-world impact in UC & Crohn’s. Experts discuss 3-year durability, rapid symptom control & what it means for patients.
#News #ECCO26 #IBD #SKYRIZI #RINVOQ #RealWorldEvidence #AbbVie

ECCO26 data reinforce long-term durability and real-world impact of AbbVie’s IBD portfolio Real-world data and three-year trial results show sustained remission and symptom control with Skyrizi and Rinvoq.

New data at ECCO 2026: Risankizumab & upadacitinib show sustained remission & real-world impact in UC & Crohn’s. Experts discuss 3-year durability, rapid symptom control & what it means for patients.
#News #ECCO26 #IBD #SKYRIZI #RINVOQ #RealWorldEvidence #AbbVie

Download our infographic on how PASS is evolving and why staying aligned with these developments is critical

The regulatory landscape for #RealWorldEvidence has accelerated over the past decade. Proactive planning and staying aligned with these developments is crucial. Stay ahead of delays, increased costs, and misalignment risks: buff.ly/OPSIGsv

#RWE #PASS #RegulatoryGuidance

The IMPACCT Real-World Evidence Summit Europe is here!

Meet with us to discuss how RWE can add value across the product lifecycle. Email contact@lumanity.com real-world-evidence-pharma-europe.com

#IMPACCTRWE #RWE #RealWorldEvidence

Real‑world evidence in Ther Adv Med Onc shows nal‑IRI/5‑FU/LV significantly improves OS in pancreatic adenocarcinoma (28.0 vs 18.3 months) despite higher cost (ICER $33,285/LYG). 🔗https://buff.ly/dOq2XvY
#PancreaticCancer #GIOnc #RealWorldEvidence #HealthEconomics

The world of clinical trials is evolving from rigid to "Pragmatic & Adaptive." ECT proves that past data can save future lives.

Have you ever worked with External Controls or Synthetic Arms? Let’s discuss below! 👇

#PeerOnSky #ClinicalTrials #ExternalControlledTrials #RealWorldEvidence

UK moves ahead with GP patient data sharing plan The UK government has asked the NHS to start putting together the platforms to allow anonymised primary care patient data to be used by researchers.

#populationhealth #patientdatasharingplan #UKgovernment #NHS #populationbasedresearchprojects #GPhealthrecords #UKBiobank #OurFutureHealth #GenomicsEngland #100000GenomesProject #NHSGPdata #humanhealth #deidentifiedhealthdata #AMRC #healthinformation #realworldevidence #patientdata
zurl.co/rw8IC

We're looking forward to the upcoming IMPACCT Real-World Evidence Summit Europe in a couple of weeks. Meet with us to discuss how RWE can add value across the product lifecycle. Email contact@lumanity.com real-world-evidence-pharma-europe.com

#IMPACCTRWE #RWE #RealWorldEvidence

FDA outlines Advancing RWE pathway, reviews guidance and submission pitfalls At an FDA Grand Rounds, Dr. Marie Bradley described the Advancing Real World Evidence pathway (launched under PDUFA VII), guidance development, common reasons RWE submissions fail, and operational advice for sponsors seeking early consultation.

Dr. Marie Bradley reveals critical insights on the FDA's new Advancing Real World Evidence pathway, sharing essential guidance for sponsors to avoid common submission pitfalls.

Learn more here!

#US #CitizenPortal #RegulatorySubmissions #FDAGrandRounds #RealWorldEvidence #DataStandards

Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial External comparator (EC) studies can improve identification of compounds with the most promising performance in pre-pivotal single-arm trials (SAT). As SAT output lacks comparative insights, EC studie...

📢New article alert

New Perspective article on "Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial"

🔗Read here: becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #TrialMethodology #RealWorldEvidence #RWE

Real‐World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR) Background The SYNAPSE phase 3 study demonstrated that mepolizumab significantly improves nasal polyp score (NPS), quality of life and symptom severity in patients with chronic rhinosinusitis with n...

📣Thrilled to share our pan-European collaboration results: mepolizumab delivers progressive,real-world benefits in #CRSwNP! Nearly 50% achieved a deep composite response at 1 year, proving the power of staying the course.A huge team effort!
#biologics #RealWorldEvidence
🔗 dx.doi.org/10.1002/clt2...

Becaris Publishing

ISPOR’s 2026–2027 Top HEOR Trends highlight the growing role of #AI, #RealWorldEvidence, and #ValueBasedHealthcare | Becaris Publishing becarispublishing.com/digital-cont...

Expanding the evidence ecosystem: How PMR enriches Meta-Analysis and Real-World Evidence in Pharma Discover how PMR deepens meta-analyses and RWE by surfacing stakeholder perspectives and real-world context.

PMR enriches meta-analyses and strengthens RWE by surfacing stakeholder views, unmet needs & context beyond data. Case studies illustrate how PMR shapes design, reveals behaviors, and turns numbers into real-world insight.

medium.com/@vishalkrast...

#PrimaryMarketResearch #RealWorldEvidence

Watch the full interview, download the infographic, and read the white paper on navigating evidence transportability in a global RWE landscape: buff.ly/ebw2AoN

#HTA #RealWorldEvidence #EvidenceTransportability #RWEStrategy #RWD

Watch the full interview, download the infographic, and read the white paper on navigating evidence transportability in a global RWE landscape: buff.ly/ebw2AoN

#HTA #RealWorldEvidence #EvidenceTransportability #RWEStrategy #RWD